Turnstone Biologics Enters Cooperative Research and Development Agreement with the National Cancer Institute to Study TIL Therapy in Combination with Viral Immunotherapy

SAN DIEGO–(BUSINESS WIRE)– #NCI–Collaboration focused on potentiating the clinical benefit of TIL therapy against solid tumors through novel combinations with viral immunotherapy
Click here to view original post